About OraSure Technologies
OraSure Technologies, Inc. (OraSure) is involved in the development, manufacture, marketing and sale of oral fluid diagnostic products and specimen collection devices using its technologies, as well as other diagnostic products, including immunoassays and other in vitro diagnostic tests that are used on other specimen types. The Company also manufactures and sells medical devices used for the removal of benign skin lesions by cryosurgery or freezing. Its diagnostic products include tests, such as OraQuick Rapid HIV Test, OraQuick In-Home HIV Test, OraQuick HIV Self-Test, OraQuick HCV Rapid Antibody Test, OraQuick Ebola Rapid Antigen Test, OraSure QuickFlu Rapid Flu A&B Test, OraSure Collection Device, Molecular Collection Systems, Cryosurgical Systems (Skin Lesion Removal Products), Immunoassay Tests and Reagents, Western blot HIV-1 Confirmatory Test and Q.E.D. Saliva Alcohol Test. Its products are sold in the United States and internationally to clinical laboratories and hospitals.
Industry, Sector and Symbol:
- Sector: Medical
- Industry: Medical Instruments & Supplies
- Sub-Industry: Health Care Supplies
- Exchange: NASDAQ
- Symbol: OSUR
- CUSIP: 68554V10
- Previous Close: $11.23
- 50 Day Moving Average: $8.88
- 200 Day Moving Average: $8.21
- 52-Week Range: $55,811,000.00 - $5.57
- Trailing P/E Ratio: 32.09
- Foreward P/E Ratio: 46.79
- P/E Growth: 1.46
- Market Cap: $626.76M
- Outstanding Shares: 55,811,000
- Beta: 1.44
- Net Margins: 15.38%
- Return on Equity: 11.64%
- Return on Assets: 9.99%
Companies Related to OraSure Technologies:
- Current Ratio: 6.87%
- Quick Ratio: 6.32%
What is OraSure Technologies' stock symbol?
OraSure Technologies trades on the NASDAQ under the ticker symbol "OSUR."
Where is OraSure Technologies' stock going? Where will OraSure Technologies' stock price be in 2017?
7 brokers have issued 12-month price objectives for OraSure Technologies' stock. Their forecasts range from $8.00 to $12.00. On average, they anticipate OraSure Technologies' stock price to reach $10.38 in the next twelve months.
When will OraSure Technologies announce their earnings?
OraSure Technologies is scheduled to release their next quarterly earnings announcement on Tuesday, May, 2nd 2017.
What are analysts saying about OraSure Technologies stock?
Here are some recent quotes from research analysts about OraSure Technologies stock:
According to Zacks Investment Research, "OraSure Technologies, Inc. is the market leader for oral fluid diagnostics. The Company develops, manufactures, and markets medical devices and diagnostic products for use by insurance companies, public health agencies, clinical laboratories, physicians' offices, and workplace sites. " (2/11/2017)
BTIG Research analysts commented, "While we do not see any meaningful negatives for OSUR shares and see room for slight appreciation over time, we feel a lot of good news and higher expectations are now built into shares and would prefer a better entry point," analyst Karen Koski wrote in a note.Related Link: How The Zika Virus Spread While Congress With Out On RecessHowever, Koski acknowledged the company's new $18 million HCV test contract, improving operating margins, and a solid balance sheet. But, the analyst prefers to stay on sidelines due to the OraSure's "lumpy sales."Though OSUR has met or exceeded its sales guidance every quarter for the past several years, investors care most about HCV testing and DNAG sales, which can be lumpy," (9/19/2016)
Who owns OraSure Technologies stock?
OraSure Technologies' stock is owned by a number of of retail and institutional investors. Top institutional investors include Renaissance Technologies LLC (7.52%), Dimensional Fund Advisors LP (4.48%), State Street Corp (2.42%), AQR Capital Management LLC (2.13%), Thrivent Financial for Lutherans (0.87%) and Two Sigma Investments LP (0.80%). Company insiders that own OraSure Technologies stock include Charles W Patrick, Douglas A Michels, Jack E Jerrett, Mark L Kuna, Michael Celano, Ronald H Spair and Stephen S Phd Tang.
Who sold OraSure Technologies stock? Who is selling OraSure Technologies stock?
OraSure Technologies' stock was sold by a variety of institutional investors in the last quarter, including Bogle Investment Management L P DE, Oxford Asset Management, Two Sigma Investments LP, GSA Capital Partners LLP, Dynamic Technology Lab Private Ltd, GRT Capital Partners L.L.C., Metropolitan Life Insurance Co. NY and Systematic Financial Management LP. Company insiders that have sold OraSure Technologies stock in the last year include Charles W Patrick, Douglas A Michels, Jack E Jerrett, Mark L Kuna, Michael Celano, Ronald H Spair and Stephen S Phd Tang.
Who bought OraSure Technologies stock? Who is buying OraSure Technologies stock?
OraSure Technologies' stock was acquired by a variety of institutional investors in the last quarter, including Dimensional Fund Advisors LP, Sicart Associates LLC, Russell Investments Group Ltd., Renaissance Technologies LLC, Cadence Capital Management LLC, State Street Corp, Cornercap Investment Counsel Inc. and Allianz Asset Management AG.
How do I buy OraSure Technologies stock?
Shares of OraSure Technologies can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
How much does a share of OraSure Technologies stock cost?
One share of OraSure Technologies stock can currently be purchased for approximately $11.23.